Apigenin significantly increased retention of immune cells in the periphery and decreased expression of α4 integrin and CLEC12A on splenic dendritic cells in the autoimmune encephalomyelitis mice model. The study suggested that it could be a better treatment for the management of multiple sclerosis as compared to available treatment. This evidence concerns the gene CLEC12A and multiple sclerosis.